Conference abstract · 19 Jun 2017
Conference abstractPublished 22 Oct 2018
Why Suture less in Aortic Valve Replacement?
San Gaudenzio Clinic, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aortic valve replacement (AVR) via a median sternotomy approach, has been largely shown to be safe and long-term efficacious, and thus currently represents the â??gold-standard” approach for aortic stenosis treatment. Over the past two decades the number of AVR interventions has dramatically increased with outcomes that have improved despite the increasing age of patients that carry a growing burden of comorbidities. Octogenarians and high-risk patients, who were contraindicated for surgery in the past, currently represent a considerable portion of daily surgical activity, with increased survival and functional benefits being reported afterwards. Nevertheless, until recent years there were reports of a significant rate of patients who were deemed inoperable and so turned down for AVR mostly based on age and subjective estimation of procedural risk. This observation has recently triggered the development of less invasive interventions such as percutaneous trans-catheter aortic valve implantation (TAVI) and minimally invasive aortic valve replacement, to reduce the traumatic impact of the surgical procedure, thus fulfilling lower risk patientsâ?? expectations on the one hand and extending the operability toward increasingly high-risk patients on the other. In this setting, minimally invasive AVR (Mini-AVR), by allowing reduced surgical dissection, may lead to lower blood loss, wound complications, postoperative pains, improved postoperative respiratory recovery, earlier mobilization and functional recovery. However, due to the technical challenges involved and the lack of robust data showing a substantial survival benefit and a reduced occurrence of major post-operative complications from MI-AVR over conventional management, this approach has not been universally adopted. Opponents of minimally invasive AVR claim that potential advantages (reduced surgical chest trauma and improved cosmetic) are counterbalanced by longer cross-clamp and cardiopulmonary bypass (CPB) duration, which are associated with poorer outcomes. However, the introduction of suture less bio-prosthesis and Rapid Deployment Valve (RDV), has transformed the Mini-AVR easier, more fast and reproducible. In our personal experience in the last five years, we treated all patients in Mini-AVR with those new surgical prostheses and we consider TAVI in high risk/inoperable patients and in octogenarian. We have compared clinical results of surgical treatment of isolated aortic stenosis (mini-AVR/standard AVR/ TAVI) in our Center and we have observed that mortality rate has decreased (from 3% to 1 % in the last 5 years) and the Logistic Euroscore has increased (from 7% to 12% in the same period). Furthermore, our experience with more than 250 cases, RDV showed good outcomes at discharge and 24 months with an excellent haemodynamic profile exhibiting no severe prosthesis â?? patient â?? mismatch, even in patients with a small annulus. Para valvular leaks were non-existent or trivial in all cases. These preliminary results suggest potentially advantage of RDV in patients with small aortic annulus
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Editorial · 25 Aug 2017
Does the Future Need Sutures? - Sutureless Aortic Valve Replacement: State of-the-Art
Conference abstract · 1 Aug 2016
Suture less aortic bio prostheses a reliable tool for avr in high risk patients
Article · 31 Dec 2024
Beyond the valve: Lessons learned and future directions for trans-catheter aortic valve replacement in resourceconstrained settings
Perspective · 29 Jun 2023
Surgical Valve Replacement and Transcatheter Valve Replacement in Aortic Valve Disease: A Comprehensive Comparison
More from this journal
The newest in Clinical and Experimental Cardiology.
Short communication · 4 Aug 2026
An effective determination method for aortic valve replacement through minimally invasive lower median sternotomy
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Gian Luca Martinelli”

